Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment.

MLA

Gannon, Philippe O., et al. “Development of an Optimized Closed and Semi-Automatic Protocol for Good Manufacturing Practice Manufacturing of Tumor-Infiltrating Lymphocytes in a Hospital Environment.” Cytotherapy, vol. 22, no. 12, Dec. 2020, pp. 780–91. EBSCOhost, https://doi.org/10.1016/j.jcyt.2020.07.011.

APA

Gannon, P. O., Harari, A., Auger, A., Murgues, C., Zangiacomi, V., Rubin, O., Ellefsen Lavoie, K., Guillemot, L., Navarro Rodrigo, B., Nguyen-Ngoc, T., Rusakiewicz, S., Rossier, L., Boudousquié, C., Baumgaertner, P., Zimmermann, S., Trueb, L., Iancu, E. M., Sempoux, C., Demartines, N., … Kandalaft, L. E. (2020). Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment. Cytotherapy, 22(12), 780–791. https://doi.org/10.1016/j.jcyt.2020.07.011

Chicago

Gannon, Philippe O, Alexandre Harari, Aymeric Auger, Clément Murgues, Vincent Zangiacomi, Olivier Rubin, Kim Ellefsen Lavoie, et al. 2020. “Development of an Optimized Closed and Semi-Automatic Protocol for Good Manufacturing Practice Manufacturing of Tumor-Infiltrating Lymphocytes in a Hospital Environment.” Cytotherapy 22 (12): 780–91. doi:10.1016/j.jcyt.2020.07.011.